Navigation Links
Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait
Date:6/30/2009

CITY OF INDUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-FirstCall/ -- EFT BioTech Holdings, Inc. (Pink Sheets: EFTB), announced today that Excalibur's Ocean LaLa has successfully completed its inaugural Taiwan Strait passenger voyage which has been highlighted in multiple news articles and internet news sites, including the Taiwan Sun, and the Qatar Tribune. The article states:

"A Taiwan company launched a cruise service with China on Sunday, making it the first such cross-strait service in 60 years.

"With a band playing and dragon dance performing on shore, the 2,292-tonne Ocean LaLa set sail from the Taichung Harbour for Xiamen, China, carrying 179 passengers and 23 crew.

"The voyage across the Taiwan Strait takes only four-and-a-half-hours, but it took Taiwan and China 60 years to ease tension and for Taipei to agree to lift the ban on sea links with the mainland."

The Excalibur International Marine Corp, operator of the cruise service, said that in the initial stage, the Taichung-Xianmen cruise is an irregular service chartered by travel agencies.

"Eventually it will become a regular cruise service going not only to Xiamen, but also to other Chinese ports like Fuzhou and Shanghai," said Han Chih-yang, Excalibur's deputy.

"We are full of confidence for the future of cross-strait tourism, so we are seeking to buy two larger ships for launching regular cross-strait service," he said.

Jack Qin, the President and CEO of EFT BioTech Holdings, stated, "We are excited to be recognized by the world press and this article shows that people are truly interested in this much needed passenger and cargo service."

About EFT BioTech Holdings, Inc.

EFT BioTech Holdings, Inc. is a Nevada holding company which conducts its business through its wholly-owned subsidiary, EFT Biotech Holdings, Inc., and its wholly owned subsidiaries and various vested interests. EFT BioTech Holdings, Inc. is an e-commerce company serving consumers with EFT's "made in USA" neutraceuticals, health and beauty EFT branded products through its proprietary online business platform and website, www.eftb.us. Although our products are available for sale throughout the world, most affiliates and consumers are located in China and Hong Kong. The contents of the Company's website are not incorporated by reference herein.

Safe Harbor for Forward-Looking Statements

Statements made in this release with the respect to the Company's current plans, estimates, strategies and beliefs and other statements that are not historical are forward-looking statements. Forward-looking statements include, but are not limited to, those statements using words such as "believe," "expect," "plans," "strategy," prospects," "forecast," "estimate," "project," "anticipate," "aim," "may" or "might" and words of similar meaning in connection with a discussion of future operations, financial performance, events or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management's assumptions and belief in light of the information currently available to it. The company cautions you that a number of important risks and uncertainties could cause actual results to materially differ from those discussed in the forward-looking statements, and therefore, you should not place undue reliance on them. You also should not rely on any obligation of the Company to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The company disclaims any such obligation unless required by law. Risks and uncertainties that might affect the Company include, but are not limited to (i) the global economic environment in which the Company operates, as well as the economic conditions in the Company's markets, (ii) levels of consumer spending, and (iii) exchange rates, particularly between the Chinese Yen and the U.S. Dollar. Risks and uncertainties also include the impact of any future events with material adverse impacts.

    For More Information, Please Contact:
    Aero Strategic Advisory, A division of Aero Financial, Inc.
    Ed Carter
    Telephone: 702-982-7732


'/>"/>
SOURCE EFT BioTech Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Excalibur - Transforming Biotech Deals can Still be Achieved
2. Excalibur Celebrates PIramed Sale With Substantial Cash Return to Investors
3. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
4. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
5. Cord Blood America Continues International Expansion
6. PAREXEL International to Present at the Wachovia Equity Conference
7. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
8. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
9. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
10. Yongye Biotechnology International Receives License to Manufacture Products
11. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The study scope includes key agricultural biotechnology ... biology tools and genome editing tools); synthetic biology-enabled chemicals and ... products are analyzed to determine present and future market sizes, ...
(Date:3/28/2017)... California (PRWEB) , ... March 28, 2017 , ... ... its flagship product, AllegroGraph , has been named a ‘Champion’ by Bloor Research ... is the highest ranked product in its class, and, thanks to Gruff, it was ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017  (AACR17, Booth ... sequencing during the American Association for Cancer Research (AACR) ... in Washington, D.C. , April 1-5, ... expression of thousands of cells at the individual level. ... Experts on-hand at AACR to discuss expanded next ...
(Date:3/28/2017)... , March 28, 2017 Biostage, ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, today announced that Jim McGorry, CEO ... and BioEngineering panel at the MassBio 2017 ... 2:30 PM ET in Cambrige, Massachussetts. The 3D ...
Breaking Biology Technology:
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... NEW YORK , March 21, 2017 /PRNewswire/ ... Customer Marketing Cloud used by retailers such as ... in its platform — Product Recommendations and Replenishment. Using ... to give more personalized product and replenishment recommendations ... purchases, but also on predictions of customer intent ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
Breaking Biology News(10 mins):